Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
While healthcare stocks may not elicit the same excitement from investors that other higher-growth sectors do, this space features a significant collection of companies with attractive track records of driving returns in many different types of markets. In general, healthcare-centric businesses tend to be more resilient in recessions and bear markets because consumers still need the products these businesses sell, regardless of the economic environment of the moment. On that note, here are two top healthcare stocks that could make investors richer in 2022 -- and well beyond.
We discuss the market outlook and investing strategies for 2023.